Title:
COMPOSITION AND METHOD FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES
Document Type and Number:
Japanese Patent JP2014196359
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide compositions and methods for treatment of autoimmune and other diseases.SOLUTION: There are provided methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also there are provided CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates. In one aspect, the invention features a method of treating an autoimmune disease in a subject, e.g., a human subject, comprising administering a CDP-therapeutic agent conjugate, particle or composition to the subject, e.g., a human subject, in an amount effective to treat the disease.
More Like This:
| WO/2002/051432 | A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME |
| WO/2013/133221 | micro-RNA INHIBITOR |
| WO/1998/001163 | PSEUDOPOLYROTAXANES |
Inventors:
SCOTT D ELIASOF
Application Number:
JP2014147399A
Publication Date:
October 16, 2014
Filing Date:
July 18, 2014
Export Citation:
Assignee:
CERULEAN PHARMA INC
International Classes:
A61K47/48; A61K9/14; A61K31/167; A61K31/337; A61K31/352; A61K31/427; A61K31/436; A61K31/4706; A61K31/4745; A61K31/506; A61K31/513; A61K31/519; A61K31/573; A61K31/616; A61K31/663; A61K31/727; A61K38/00; A61K38/55; A61K39/395; A61K45/00; A61K47/40; A61P7/02; A61P19/02; A61P29/00; A61P33/06; A61P35/00; A61P37/02; A61P43/00
Domestic Patent References:
| JP2006502301A | 2006-01-19 | |||
| JP2006513992A | 2006-04-27 |
Foreign References:
| WO2008076333A2 | 2008-06-26 |
Other References:
ＣＬＩＮＩＣＡＬ ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 15, no. 13, JPN6014002032, 2009, pages 4365 - 4373, ISSN: 0003351316
ＡＤＶＡＮＣＥＤ ＤＲＵＧ ＤＥＬＩＶＥＲＹ ＲＥＶＩＥＷＳ, vol. 61, no. 13, JPN6014002034, 2009, pages 1189 - 1192, ISSN: 0003351317
ＣＬＩＮＩＣＡＬ ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 12, no. 5, JPN6014002036, 2006, pages 1606 - 1614, ISSN: 0003351318
ＰＲＯＣ．ＮＡＴＬ．ＡＣＡＤ．ＳＣＩ．ＵＳＡ, vol. 106, no. 27, JPN6014002039, 2009, pages 11394 - 11399, ISSN: 0003351319
ＢＩＯＣＯＮＪＵＧＡＴＥ ＣＨＥＭＩＳＴＲＹ, vol. 17, no. 6, JPN6014002040, 2006, pages 1624 - 1626, ISSN: 0003351320
ＩＮＴＥＲＮＡＴＩＯＮＡＬ ＪＯＵＲＮＡＬ ＯＦ ＮＡＮＯＭＥＤＩＣＩＮＥ, vol. 3, no. 3, JPN6014002042, 2008, pages 359 - 371, ISSN: 0003351321
ＣＬＩＮＩＣＡＬ ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 15, no. 1, JPN6014002044, 2009, pages 181 - 189, ISSN: 0003351322
ＡＤＶＡＮＣＥＤ ＤＲＵＧ ＤＥＬＩＶＥＲＹ ＲＥＶＩＥＷＳ, vol. 61, no. 13, JPN6014002034, 2009, pages 1189 - 1192, ISSN: 0003351317
ＣＬＩＮＩＣＡＬ ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 12, no. 5, JPN6014002036, 2006, pages 1606 - 1614, ISSN: 0003351318
ＰＲＯＣ．ＮＡＴＬ．ＡＣＡＤ．ＳＣＩ．ＵＳＡ, vol. 106, no. 27, JPN6014002039, 2009, pages 11394 - 11399, ISSN: 0003351319
ＢＩＯＣＯＮＪＵＧＡＴＥ ＣＨＥＭＩＳＴＲＹ, vol. 17, no. 6, JPN6014002040, 2006, pages 1624 - 1626, ISSN: 0003351320
ＩＮＴＥＲＮＡＴＩＯＮＡＬ ＪＯＵＲＮＡＬ ＯＦ ＮＡＮＯＭＥＤＩＣＩＮＥ, vol. 3, no. 3, JPN6014002042, 2008, pages 359 - 371, ISSN: 0003351321
ＣＬＩＮＩＣＡＬ ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 15, no. 1, JPN6014002044, 2009, pages 181 - 189, ISSN: 0003351322
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Natsuki Morishita
Previous Patent: MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES
Next Patent: ORALLY RAPIDLY DISINTEGRATING TABLET AND PROCESS FOR PRODUCING THE SAME
Next Patent: ORALLY RAPIDLY DISINTEGRATING TABLET AND PROCESS FOR PRODUCING THE SAME